On a molecular level, FTD is characterized by aggregation of either microtubule-associated protein tau (MAPT), TAR DNA-binding protein 43 (TDP-43), or fused-in-sarcoma (FUS) (3). The gene discussed is TARDBP; the disease is frontotemporal dementia.